User profiles for U. Peters

Ulrike Peters

- Verified email at fredhutch.org - Cited by 45704

Ubong Peters

- Verified email at gene.com - Cited by 1882

Obesity and asthma

U Peters, AE Dixon, E Forno - Journal of Allergy and Clinical immunology, 2018 - Elsevier
… Author links open overlay panel Ubong Peters PhD a , Anne E. Dixon MA, BM, BCh a , Erick
… List of Design Committee Members: Ubong Peters, PhD, Anne E. Dixon, MA, BM, BCh, and …

The effect of obesity on lung function

AE Dixon, U Peters - Expert review of respiratory medicine, 2018 - Taylor & Francis
Introduction: There is a major epidemic of obesity, and many obese patients suffer with
respiratory symptoms and disease. The overall impact of obesity on lung function is multifactorial, …

Genetic susceptibility to cancer: the role of polymorphisms in candidate genes

…, JD Potter, E White, CM Ulrich, LR Cardon, U Peters - Jama, 2008 - jamanetwork.com
Context Continuing advances in genotyping technologies and the inclusion of DNA collection
in observational studies have resulted in an increasing number of genetic association …

K-Ras (G12C) inhibitors allosterically control GTP affinity and effector interactions

JM Ostrem, U Peters, ML Sos, JA Wells, KM Shokat - Nature, 2013 - nature.com
Somatic mutations in the small GTPase K-Ras are the most common activating lesions found
in human cancer, and are generally associated with poor response to standard therapies 1 …

Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use

…, KL Mohlke, JB Nielsen, Y Okada, U Peters… - Nature …, 2019 - nature.com
Tobacco and alcohol use are leading causes of mortality that influence risk for many complex
diseases and disorders 1 . They are heritable 2 , 3 and etiologically related 4 , 5 behaviors …

[HTML][HTML] Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for …

…, M Just, N Harbeck, C Schumacher, U Peters… - Annals of …, 2021 - Elsevier
Background In the phase III IMpassion130 trial, combining atezolizumab with first-line
nanoparticle albumin-bound-paclitaxel for advanced triple-negative breast cancer (aTNBC) …

Genetic analyses of diverse populations improves discovery for complex traits

…, RJF Loos, TC Matise, KE North, U Peters… - Nature, 2019 - nature.com
Genome-wide association studies (GWAS) have laid the foundation for investigations into the
biology of complex traits, drug development and clinical guidelines. However, the majority …

Detectable clonal mosaicism and its relationship to aging and cancer

…, R McKean-Cowdin, DS Michaud, BS Melin, U Peters… - Nature …, 2012 - nature.com
In an analysis of 31,717 cancer cases and 26,136 cancer-free controls from 13 genome-wide
association studies, we observed large chromosomal abnormalities in a subset of clones in …

[PDF][PDF] Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor

MR Janes, J Zhang, LS Li, R Hansen, U Peters, X Guo… - Cell, 2018 - cell.com
KRAS G12C was recently identified to be potentially druggable by allele-specific covalent
targeting of Cys-12 in vicinity to an inducible allosteric switch II pocket (S-IIP). Success of this …

Whole‐genome sequencing identifies EN1 as a determinant of bone density and fracture

…, Y Zhou, S Calderari, J Van Rooij, C Carlson, U Peters… - Nature, 2015 - nature.com
The extent to which low‐frequency (minor allele frequency (MAF) between 1–5%) and rare (MAF
≤ 1%) variants contribute to complex traits and disease in the general population is …